Abiopharma

🔍 Totsky Joanna M. (Executive)

Company: TORO CO (TTC)

Report Date: 2026-06-22

Detailed Transactions and Holdings:

• Acquired 4,859 shares of Common Stock at $92.19 per share (Direct)
  Date: 2026-06-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,887.99 | transaction_form_type: 4
• Sold 2,168 shares of Common Stock at $92.19 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 7,719.99 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-22 | Code: H | nature_of_ownership: The Toro Company Retirement Plan | shares_owned_after: 1.04 | Footnotes: F1
• Sold 4,859 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-22 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F3
• Holds 2,714 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-22 | Code: H | shares_owned_after: 2,713.78 | Footnotes: F2, F4, F4

Footnotes:

• F1: Includes 0.008 shares of common stock acquired under the dividend reinvestment feature of the The Toro Company Retirement Plan since the date of her last report.
• F2: Each restricted stock unit represents a contingent right to receive one share of TTC common stock.
• F3: The restricted stock units and related dividend equivalents vest in three equal annual installments commencing on the first anniversary of the June 20, 2023 grant date.
• F4: The restricted stock units and related dividend equivalents vest in three equal annual installments commencing on the first anniversary of the December 22, 2025 grant date.